Allianz Asset Management
CLVS

Allianz Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Allianz Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-31,436
Closed -$125K – 2883
2019
Q3 		$125K Buy
31,436
+9,098
+41% +$73.6K ﹤0.01% 2676
2019
Q2 		$332K Sell
22,338
-13,222
-37% -$239K ﹤0.01% 2476
2019
Q1 		$883K Buy
+35,560
New +$891K ﹤0.01% 2139
2018
Q4 		– Sell
-50,665
Closed -$1.49M – 2732
2018
Q3 		$1.49M Sell
50,665
-144,760
-74% -$5.6M ﹤0.01% 2068
2018
Q2 		$8.89M Sell
195,425
-5,203
-3% -$253K 0.01% 1301
2018
Q1 		$10.6M Sell
200,628
-39,663
-17% -$2.31M 0.01% 1227
2017
Q4 		$16.3M Sell
240,291
-17,693
-7% -$1.24M 0.01% 1075
2017
Q3 		$21.3M Buy
257,984
+115,991
+82% +$9.2M 0.02% 931
2017
Q2 		$13.2M Buy
141,993
+105,455
+289% +$6.45M 0.01% 1182
2017
Q1 		$2.33M Buy
+36,538
New +$2.22M ﹤0.01% 1943
2016
Q2 		– Sell
-186,084
Closed -$3.57M – 2632
2016
Q1 		$3.57M Buy
186,084
+15,404
+9% +$326K ﹤0.01% 1575
2015
Q4 		$5.92M Buy
170,680
+7,370
+5% +$475K 0.01% 1287
2015
Q3 		$15M Buy
163,310
+64,095
+65% +$5.55M 0.02% 821
2015
Q2 		$8.72M Sell
99,215
-99,695
-50% -$8.53M 0.01% 1158
2015
Q1 		$14.8M Sell
198,910
-315
-0.2% -$22.2K 0.02% 791
2014
Q4 		$11.2M Buy
199,225
+162,145
+437% +$8.52M 0.01% 917
2014
Q3 		$1.68M Buy
37,080
+1,175
+3% +$49.1K ﹤0.01% 1493
2014
Q2 		$1.49M Buy
+35,905
New +$1.85M ﹤0.01% 1291

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Allianz Asset Management's CLVS Position: Q4 2019 in Review

Allianz Asset Management sold out of Clovis Oncology, Inc. (CLVS) in Q4 2019, closing a stake of 31,436 shares — an estimated $125K sold.

Allianz Asset Management first reported a position in CLVS in Q2 2014 and held it in 18 quarters. The position peaked at $21.3M in Q3 2017. 147 funds tracked by Wall St. Rank hold CLVS as of Q4 2019.

  • Allianz Asset Management reported no remaining Clovis Oncology, Inc. position as of Q4 2019 after selling out during the quarter.
  • Allianz Asset Management sold 31,436 Clovis Oncology, Inc. shares in Q4 2019, an estimated $125K.
  • Allianz Asset Management first reported a position in Clovis Oncology, Inc. in Q2 2014 and held it in 18 quarters.
  • Allianz Asset Management's Clovis Oncology, Inc. position peaked at $21.3M in Q3 2017.
  • 147 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2019.

Based on Allianz Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.